Your browser doesn't support javascript.
loading
Risk Factors Associated with Recurrent Clostridioides difficile Infection.
Negrut, Nicoleta; Bungau, Simona; Behl, Tapan; Khan, Shamim Ahmad; Vesa, Cosmin Mihai; Bustea, Cristiana; Nistor-Cseppento, Delia Carmen; Rus, Marius; Pavel, Flavia-Maria; Tit, Delia Mirela.
Affiliation
  • Negrut N; Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.
  • Bungau S; Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 N. Jiga St., 410028 Oradea, Romania.
  • Behl T; Department of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
  • Khan SA; Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Vesa CM; Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Bustea C; Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Nistor-Cseppento DC; Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.
  • Rus M; Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Pavel FM; Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  • Tit DM; Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 N. Jiga St., 410028 Oradea, Romania.
Healthcare (Basel) ; 8(3)2020 Sep 21.
Article in En | MEDLINE | ID: mdl-32967323
Clostridioides difficile (CD) is responsible for nosocomial diarrhea syndrome with possible severe progression. Recurrence of the disease induces higher health system costs, as well as exposes patients to additional health risks. Patients with recurrence of this disease are difficult to identify, so the purpose of this study is to quantify various demographic, clinical, and treatment factors that could prevent further progression to recurrence of the disease. In the period 2018-2019, about 195 patients were diagnosed with more than one episode of CDI in the three months following the first episode. The recurrence rate for CDI was 53.84% (60.95% for one episode and 39.05% for multiple episodes). Most commonly afflicted were 60-69-year-old patients, or those with higher Charlson Comorbidity Index (CCI). Multiple analyses associated cardiovascular (odds ratios (OR) = 3.02, 95% confidence intervals (CI) = 1.23-7.39, p = 0.015), digestive (OR = 3.58, 95% CI = 1.01-12.63, p = 0.047), dementia (OR = 3.26, 95% CI = 1.26-8.41, p = 0.014), immunosuppressive (OR = 3.88, 95% CI = 1.34-11.21, p = 0.012) comorbidities with recurrences. Risk factor identification in the first episode of CDI could lead to the implementation of treatment strategies to improve the patients' quality of life affected by this disease.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Healthcare (Basel) Year: 2020 Document type: Article Affiliation country: Romania Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Healthcare (Basel) Year: 2020 Document type: Article Affiliation country: Romania Country of publication: Switzerland